Citation Impact
Citing Papers
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
2009 StandoutScience
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Plant Cuticular Lipid Export Requires an ABC Transporter
2004 StandoutScience
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.
2001
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors
2002
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression
1997
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Simultaneous Activity of MRP1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia
1999
Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation
2004
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
2000
An inventory of the human ABC proteins
1999
Specific posttranslational modification regulates early events in mammary carcinoma formation
2010
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
2002
Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance
2005
P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications
1999
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
ABCG2 (BCRP) expression in normal and malignant hematopoietic cells
2003
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma Membrane
2000
Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines
2001
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Drug penetration in solid tumours
2006 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Anticancer therapy with novel tubulin-interacting drugs
2001
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
2001
Dominant‐negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S‐S dependent homodimerization
2001
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma
2002
ABC Transporters, Drug Resistance, and Cancer Stem Cells
2009
Resistance to antifolates
2003
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Targeting multidrug resistance in cancer
2006 Standout
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Breast Cancer Resistance Protein (BCRP/ABCG2) Induces Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase Inhibitors
2003
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.
2005
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
2012
Malignant Gliomas in Adults
2008 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
2001
Hematopoietic Stem-Cell Transplantation
2006 Standout
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
2001
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
2003
Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells
2001
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
2004
Multidrug resistance related molecules in human and murine lung
2002
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2003 Standout
Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan
2007
Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP
2002
Microtubules as a target for anticancer drugs
2004 Standout
Prenylated indole derivatives from fungi: structure diversity, biological activities, biosynthesis and chemoenzymatic synthesis
2009 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Hematopoietic and nonhematopoietic potentials of Hoechstlow/side population cells isolated from adult rat kidney
2004 StandoutNobel
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin
2003
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
2004
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
2000
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
2001
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer
2006
Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization
2001
Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters
2005
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediates Resistance to Mitoxantrone via Glutathione-Dependent Drug Efflux
2006
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
2003
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.
2002
3d Transition Metals for C–H Activation
2018 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Tumour stem cells and drug resistance
2005 Standout
Prognostic Value of the Cu-Transporting ATPase in Ovarian Carcinoma Patients Receiving Cisplatin-Based Chemotherapy
2004
Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
1997
Breast Cancer Resistance Protein in Drug Resistance of Primitive CD34+38− Cells in Acute Myeloid Leukemia
2005
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
2008
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Expression and functional analyses of breast cancer resistance protein in lung cancer.
2003
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Synthesis of 1,1-disubstituted tetrahydro-β-carbolines from 2-methyleneaziridines
2008
Current states and future views in photodynamic therapy
2011
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
2000
Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)
2005
Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia
2003
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein
2004
Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
1985 Standout
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
2000
Total synthesis of natural productsviairidium catalysis
2017
DAF-16 Target Genes That Control C. elegans Life-Span and Metabolism
2003 StandoutScienceNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells.
1983
Unlocking Reactivity of TrpB: A General Biocatalytic Platform for Synthesis of Tryptophan Analogues
2017 StandoutNobel
Mammalian ABC Transporters in Health and Disease
2002
Natural Product Synthesis by C−H Activation
2018
Total Synthesis of Verruculogen and Fumitremorgin A Enabled by Ligand-Controlled C–H Borylation
2015
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
2000
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
2005
Side population cells and Bcrp1 expression in lung
2003
Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
2001
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
2001
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.
2001
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
2004
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
2007
Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
2003
FaDu cell characteristics induced by multidrug resistance
2011
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
1999
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
2000
Works of D D Ross being referenced
Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
1996
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
2001
Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
1998
Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling
2010
Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines
1999
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function
2004
H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein.
1996
Variation amongst K562 cell cultures.
1983
Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux.
2000
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.
2000
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
1997